Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1985 3
1986 1
1987 2
1988 2
1989 4
1990 3
1991 2
1992 1
1993 4
1994 1
1995 2
1997 2
1998 2
1999 5
2000 5
2001 8
2002 6
2003 7
2004 12
2005 11
2006 10
2007 11
2008 7
2009 7
2010 8
2011 5
2012 2
2013 6
2014 3
2015 3
2016 1
2020 1
Text availability
Article attribute
Article type
Publication date

Search Results

140 results
Results by year
Filters applied: . Clear all
Page 1
Pioglitazone stimulates AMP-activated protein kinase signalling and increases the expression of genes involved in adiponectin signalling, mitochondrial function and fat oxidation in human skeletal muscle in vivo: a randomised trial.
Coletta DK, Sriwijitkamol A, Wajcberg E, Tantiwong P, Li M, Prentki M, Madiraju M, Jenkinson CP, Cersosimo E, Musi N, Defronzo RA. Coletta DK, et al. Diabetologia. 2009 Apr;52(4):723-32. doi: 10.1007/s00125-008-1256-9. Epub 2009 Jan 24. Diabetologia. 2009. PMID: 19169664 Free PMC article. Clinical Trial.
Hypercalcemia of malignancy.
Mundy GR, Guise TA. Mundy GR, et al. Am J Med. 1997 Aug;103(2):134-45. doi: 10.1016/s0002-9343(97)80047-2. Am J Med. 1997. PMID: 9274897 Review. No abstract available.
Recent advances in pathophysiology and treatment of hypercalcemia of malignancy.
Mundy GR, Yates AJ. Mundy GR, et al. Am J Kidney Dis. 1989 Jul;14(1):2-12. doi: 10.1016/s0272-6386(89)80086-1. Am J Kidney Dis. 1989. PMID: 2662763 Review. No abstract available.
Pathogenesis of hypercalcaemia of malignancy.
Mundy GR. Mundy GR. Clin Endocrinol (Oxf). 1985 Dec;23(6):705-14. doi: 10.1111/j.1365-2265.1985.tb01132.x. Clin Endocrinol (Oxf). 1985. PMID: 3006948 Review.
Cytokines and growth factors in the regulation of bone remodeling.
Mundy GR. Mundy GR. J Bone Miner Res. 1993 Dec;8 Suppl 2:S505-10. doi: 10.1002/jbmr.5650081315. J Bone Miner Res. 1993. PMID: 7510095 Review.
A phase I study of pivaloyloxymethyl butyrate, a prodrug of the differentiating agent butyric acid, in patients with advanced solid malignancies.
Patnaik A, Rowinsky EK, Villalona MA, Hammond LA, Britten CD, Siu LL, Goetz A, Felton SA, Burton S, Valone FH, Eckhardt SG. Patnaik A, et al. Clin Cancer Res. 2002 Jul;8(7):2142-8. Clin Cancer Res. 2002. PMID: 12114414 Free article. Review.
Genetic determinants of mitochondrial content.
Curran JE, Johnson MP, Dyer TD, Göring HH, Kent JW, Charlesworth JC, Borg AJ, Jowett JB, Cole SA, MacCluer JW, Kissebah AH, Moses EK, Blangero J. Curran JE, et al. Hum Mol Genet. 2007 Jun 15;16(12):1504-14. doi: 10.1093/hmg/ddm101. Epub 2007 Apr 27. Hum Mol Genet. 2007. PMID: 17468176
What is the best predictor of future type 2 diabetes?
Abdul-Ghani MA, Williams K, DeFronzo RA, Stern M. Abdul-Ghani MA, et al. Diabetes Care. 2007 Jun;30(6):1544-8. doi: 10.2337/dc06-1331. Epub 2007 Mar 23. Diabetes Care. 2007. PMID: 17384342
140 results
Jump to page
Feedback